Q2 2025 GE Healthcare Technologies Inc Earnings Call Transcript
Key Points
- GE HealthCare Technologies Inc (GEHC) reported strong orders growth across all segments, with a record backlog of $21.3 billion, indicating robust customer demand.
- The company secured significant strategic collaborations, including a $250 million five-year deal in Europe and a $90 million collaboration with Ascension in the US.
- GEHC's new product introductions generated over 50% of sales, demonstrating the success of their R&D investments.
- The company delivered strong adjusted EPS of $1.06 per share, up 6% year over year, despite macroeconomic challenges.
- GEHC raised its full-year 2025 guidance for organic revenue growth to approximately 3% and adjusted EPS to between $4.43 and $4.63, reflecting confidence in future performance.
- Adjusted EBIT margin declined by 80 basis points year over year due to tariff impacts, affecting overall profitability.
- Organic revenue in the Imaging segment was up only 1% due to headwinds in China, impacting overall segment performance.
- Patient Care Solutions segment saw a decline in EBIT margin by 240 basis points, primarily due to inflation and unfavorable portfolio mix.
- The company faced a 180 basis point decline in adjusted gross margin year over year, driven by tariff expenses and new product investments.
- China's market recovery is taking longer than expected, with tender cycles extending, leading to a more conservative outlook for the region in the second half of the year.
Good day, and thank you for standing by. Welcome to the GE HealthCare Second Quarter 2025 Earnings Conference Call. (Operator Instructions) Please be advised today's conference is being recorded. I would now like to turn the conference over to your speaker today, Carolynne Borders. Please go ahead.
Thanks, operator. Good morning, and welcome to GE HealthCare's second quarter 2025 earnings call. I'm joined by our President and CEO, Peter Arduini; and Vice President and CFO, Jay Saccaro. Our conference call remarks will include both GAAP and non-GAAP financial results. Reconciliations between GAAP and non-GAAP measures can be found in today's press release and in the presentation slides available on our website.
During this call, we'll make forward-looking statements about our performance. These statements are based on how we see things today. As described in our SEC filings, actual results may differ materially due to risks and uncertainties. With that, I'll hand the call over to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
